{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:24:54Z","timestamp":1760909094285,"version":"3.41.2"},"reference-count":58,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2017.00294","type":"journal-article","created":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T04:25:12Z","timestamp":1509942312000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Human Prolactin Point Mutations and Their Projected Effect on Vasoinhibin Generation and Vasoinhibin-Related Diseases"],"prefix":"10.3389","volume":"8","author":[{"given":"Jakob","family":"Triebel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christin J.","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Leuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzalo","family":"Mart\u00ednez de la Escalera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Clapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Bertsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,11,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-3-319-12114-7_4","article-title":"Regulation of blood vessels by prolactin and vasoinhibins","volume":"846","author":"Clapp","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1152\/physrev.00024.2009","article-title":"Peptide hormone regulation of angiogenesis","volume":"89","author":"Clapp","year":"2009","journal-title":"Physiol Rev"},{"key":"B3","doi-asserted-by":"publisher","first-page":"12538","DOI":"10.1073\/pnas.1615051113","article-title":"Prolactin alters blood pressure by modulating the activity of endothelial nitric oxide synthase","volume":"113","author":"Chang","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1385\/ENDO:20:1-2:155","article-title":"Prolactin and 16K prolactin stimulate release of vasopressin by a direct effect on hypothalamo-neurohypophyseal system","volume":"20","author":"Mejia","year":"2003","journal-title":"Endocrine"},{"key":"B5","doi-asserted-by":"publisher","first-page":"13183","DOI":"10.1074\/jbc.275.18.13183","article-title":"Proteolytic cleavage confers nitric oxide synthase inducing activity upon prolactin","volume":"275","author":"Corbacho","year":"2000","journal-title":"J Biol Chem"},{"key":"B6","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nm.3552","article-title":"PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin","volume":"20","author":"Bajou","year":"2014","journal-title":"Nat Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.psyneuen.2014.03.006","article-title":"Prolactin-derived vasoinhibins increase anxiety- and depression-related behaviors","volume":"44","author":"Zamorano","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1210\/en.2009-0390","article-title":"Cathepsin D is the primary protease for the generation of adenohypophyseal vasoinhibins: cleavage occurs within the prolactin secretory granules","volume":"150","author":"Cruz-Soto","year":"2009","journal-title":"Endocrinology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.2337\/db10-0873","article-title":"High levels of serum prolactin protect against diabetic retinopathy by increasing ocular vasoinhibins","volume":"59","author":"Arnold","year":"2010","journal-title":"Diabetes"},{"key":"B10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.cell.2006.12.036","article-title":"A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy","volume":"128","author":"Hilfiker-Kleiner","year":"2007","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1242\/jcs.02887","article-title":"Matrix metalloproteases from chondrocytes generate an antiangiogenic 16 kDa prolactin","volume":"119","author":"Macotela","year":"2006","journal-title":"J Cell Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1210\/me.2004-0200","article-title":"Cathepsin D processes human prolactin into multiple 16K-like N-terminal fragments: study of their antiangiogenic properties and physiological relevance","volume":"18","author":"Piwnica","year":"2004","journal-title":"Mol Endocrinol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"10010","DOI":"10.1073\/pnas.0704179104","article-title":"Bone morphogenetic protein 1 processes prolactin to a 17-kDa antiangiogenic factor","volume":"104","author":"Ge","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B14","doi-asserted-by":"publisher","first-page":"R1193","DOI":"10.1152\/ajpregu.00256.2015","article-title":"Principles of the prolactin\/vasoinhibin axis","volume":"309","author":"Triebel","year":"2015","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1530\/EJE-09-0130","article-title":"Investigation of prolactin-related vasoinhibin in sera from patients with diabetic retinopathy","volume":"161","author":"Triebel","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1002\/iub.518","article-title":"Prolactin and vasoinhibins: endogenous players in diabetic retinopathy","volume":"63","author":"Triebel","year":"2011","journal-title":"IUBMB Life"},{"key":"B17","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s00392-015-0869-5","article-title":"Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy","volume":"104","author":"Haghikia","year":"2015","journal-title":"Clin Res Cardiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/hr.2015.99","article-title":"Elevated vasoinhibin derived from prolactin and cathepsin D activities in sera of patients with preeclampsia","volume":"38","author":"Nakajima","year":"2015","journal-title":"Hypertens Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/labinvest.3700662","article-title":"Elevated vasoinhibins may contribute to endothelial cell dysfunction and low birth weight in preeclampsia","volume":"87","author":"Gonzalez","year":"2007","journal-title":"Lab Invest"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1210\/jc.2008-0305","article-title":"Urinary prolactin as a reliable marker for preeclampsia, its severity, and the occurrence of adverse pregnancy outcomes","volume":"93","author":"Leanos-Miranda","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.18926\/AMO\/40133","article-title":"Expression of antiangiogenic prolactin fragments in the placentas of women with pregnancy induced hypertension","volume":"64","author":"Masumoto","year":"2010","journal-title":"Acta Med Okayama"},{"key":"B22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fendo.2015.00016","article-title":"On the path toward classifying hormones of the vasoinhibin-family","volume":"6","author":"Triebel","year":"2015","journal-title":"Front Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fendo.2017.00077","article-title":"Remarks on the prolactin hypothesis of peripartum cardiomyopathy","volume":"8","author":"Triebel","year":"2017","journal-title":"Front Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/978-1-62703-360-2_16","article-title":"Preparation of human serum for prolactin measurement by multiple reaction monitoring mass spectrometry","volume":"1002","author":"Waybright","year":"2013","journal-title":"Methods Mol Biol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"D662","DOI":"10.1093\/nar\/gku1010","article-title":"Ensembl 2015","volume":"43","author":"Cunningham","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1093\/molbev\/msw054","article-title":"MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets","volume":"33","author":"Kumar","year":"2016","journal-title":"Mol Biol Evol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"D777","DOI":"10.1093\/nar\/gkw1121","article-title":"COSMIC: somatic cancer genetics at high-resolution","volume":"45","author":"Forbes","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/978-1-4939-6934-0_14","article-title":"Using the MEROPS database for investigation of lysosomal peptidases, their inhibitors, and substrates","volume":"1594","author":"Rawlings","year":"2017","journal-title":"Methods Mol Biol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1101\/gr.154492.113","article-title":"Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma","volume":"23","author":"Kan","year":"2013","journal-title":"Genome Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.cell.2012.08.029","article-title":"Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing","volume":"150","author":"Imielinski","year":"2012","journal-title":"Cell"},{"key":"B31","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/ng.2983","article-title":"Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer","volume":"46","author":"Wang","year":"2014","journal-title":"Nat Genet"},{"key":"B32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature14664","article-title":"Comprehensive genomic profiles of small cell lung cancer","volume":"524","author":"George","year":"2015","journal-title":"Nature"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/ng.2396","article-title":"Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer","volume":"44","author":"Peifer","year":"2012","journal-title":"Nat Genet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/eurjhf\/hfq120","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy","volume":"12","author":"Sliwa","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.amjcard.2006.01.039","article-title":"Frequency of Peripartum Cardiomyopathy","volume":"97","author":"Mielniczuk","year":"2006","journal-title":"Am J Cardio"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1161\/CIRCULATIONAHA.115.020491","article-title":"Peripartum cardiomyopathy","volume":"133","author":"Arany","year":"2016","journal-title":"Circulation"},{"key":"B37","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.tcm.2015.01.004","article-title":"Molecular mechanisms of peripartum cardiomyopathy: a vascular\/hormonal hypothesis","volume":"25","author":"Bello","year":"2015","journal-title":"Trends Cardiovasc Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.amjcard.2007.02.092","article-title":"Incidence, mortality, and racial differences in peripartum cardiomyopathy","volume":"100","author":"Brar","year":"2007","journal-title":"Am J Cardiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/aogs.13005","article-title":"Peripartum cardiomyopathy: a systematic literature review","volume":"95","author":"Ersboll","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/0002-9378(72)90446-2","article-title":"Studies of prolactin secretion in human pregnancy","volume":"113","author":"Tyson","year":"1972","journal-title":"Am J Obstet Gynecol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.tem.2006.08.002","article-title":"Vasoinhibins: endogenous regulators of angiogenesis and vascular function","volume":"17","author":"Clapp","year":"2006","journal-title":"Trends Endocrinol Metab"},{"key":"B42","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000094309","article-title":"Vasoinhibins: a family of N-terminal prolactin fragments that inhibit angiogenesis and vascular function","volume":"35","author":"Clapp","year":"2006","journal-title":"Front Horm Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1210\/endo.133.3.7689950","article-title":"The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis","volume":"133","author":"Clapp","year":"1993","journal-title":"Endocrinology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1167\/iovs.05-0173","article-title":"Prolactins are natural inhibitors of angiogenesis in the retina","volume":"46","author":"Aranda","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B45","first-page":"2498","article-title":"Inhibition of rat corneal angiogenesis by 16-kDa prolactin and by endogenous prolactin-like molecules","volume":"40","author":"Duenas","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1172\/JCI34508","article-title":"Vasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2A-dependent eNOS inactivation","volume":"118","author":"Garcia","year":"2008","journal-title":"J Clin Invest"},{"key":"B47","doi-asserted-by":"publisher","first-page":"8944","DOI":"10.1167\/iovs.11-8190","article-title":"Vasoinhibin gene transfer by adenoassociated virus type 2 protects against VEGF- and diabetes-induced retinal vasopermeability","volume":"52","author":"Ramirez","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1167\/iovs.03-1001","article-title":"Molecular targeting of antiangiogenic factor 16K hPRL inhibits oxygen-induced retinopathy in mice","volume":"45","author":"Pan","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1167\/iovs.03-1346","article-title":"Prolactin in eyes of patients with retinopathy of prematurity: implications for vascular regression","volume":"45","author":"Duenas","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B50","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12672-010-0012-z","article-title":"16 kDa prolactin reduces angiogenesis, but not growth of human breast cancer tumors in vivo","volume":"1","author":"Faupel-Badger","year":"2010","journal-title":"Horm Cancer"},{"key":"B51","first-page":"386","article-title":"Antitumor activity of the 16-kDa prolactin fragment in prostate cancer","volume":"63","author":"Kim","year":"2003","journal-title":"Cancer Res"},{"key":"B52","first-page":"7356","article-title":"Expression of the antiangiogenic factor 16K hPRL in human HCT116 colon cancer cells inhibits tumor growth in Rag1(-\/-) mice","volume":"61","author":"Bentzien","year":"2001","journal-title":"Cancer Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1038\/sj.mt.6300294","article-title":"Inhibition of tumor growth and metastasis establishment by adenovirus-mediated gene transfer delivery of the antiangiogenic factor 16K hPRL","volume":"15","author":"Nguyen","year":"2007","journal-title":"Mol Ther"},{"key":"B54","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B55","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1677\/joe.0.175R013","article-title":"16K prolactin induces NF-kappaB activation in pulmonary fibroblasts","volume":"175","author":"Macotela","year":"2002","journal-title":"J Endocrinol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/pr.2016.241","article-title":"Higher prolactin and vasoinhibin serum levels associated with incidence and progression of retinopathy of prematurity","volume":"81","author":"Zepeda-Romero","year":"2017","journal-title":"Pediatr Res"},{"key":"B57","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10911-008-9067-7","article-title":"Role of prolactin and vasoinhibins in the regulation of vascular function in mammary gland","volume":"13","author":"Clapp","year":"2008","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"B58","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fendo.2017.00105","article-title":"Commentary: prolactin alters blood pressure by modulating the activity of endothelial nitric oxide synthase","volume":"8","author":"Triebel","year":"2017","journal-title":"Front Endocrinol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2017.00294\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T04:25:15Z","timestamp":1509942315000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2017.00294\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,6]]},"references-count":58,"alternative-id":["10.3389\/fendo.2017.00294"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2017.00294","relation":{},"ISSN":["1664-2392"],"issn-type":[{"type":"electronic","value":"1664-2392"}],"subject":[],"published":{"date-parts":[[2017,11,6]]},"article-number":"294"}}